Literature DB >> 2386154

Embryopathic effects of short-term exposure to hypoglycemia in mouse embryos in vitro.

I W Smoak1, T W Sadler.   

Abstract

The effect of short-term hypoglycemia was studied at two stages of development in postimplantation mouse embryos in vitro. Day 8 (gastrulating) mouse embryos were placed in hypoglycemic medium (60, 80, 100, or 110 mg/dl glucose) for 4 hours in which normoglycemia (120 to 150 mg/dl glucose) was restored for the remaining 44 hours of culture. Day 9 (neurulating) mouse embryos were exposed to hypoglycemia (20, 40, 60, or 80 mg/dl glucose) for 2, 4, 6, or 24 hours followed by normoglycemia for the remainder of 24 hours. At the end of culture embryos were evaluated for growth and malformations and compared with controls grown in normoglycemic medium. The results show that a 50% reduction in glucose for as little as 2 hours causes dysmorphogenesis in neurulating mouse embryos, whereas longer exposure times, more severe levels of hypoglycemia, or both are required to affect growth. Furthermore, gastrulating embryos are more sensitive to short periods of hypoglycemia than those undergoing neurulation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386154     DOI: 10.1016/0002-9378(90)91213-v

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  9 in total

1.  Treatment of gestational diabetes mellitus: glyburide compared to subcutaneous insulin therapy and associated perinatal outcomes.

Authors:  Yvonne W Cheng; Judith H Chung; Ingrid Block-Kurbisch; Maribeth Inturrisi; Aaron B Caughey
Journal:  J Matern Fetal Neonatal Med       Date:  2011-06-01

2.  Diabetic embryopathy: a developmental perspective from fertilization to adulthood.

Authors:  M Castori
Journal:  Mol Syndromol       Date:  2013-02

3.  Low and moderate prenatal ethanol exposures of mice during gastrulation or neurulation delays neurobehavioral development.

Authors:  Uta B Schambra; Jeff Goldsmith; Kevin Nunley; Yali Liu; Sam Harirforoosh; Heidi M Schambra
Journal:  Neurotoxicol Teratol       Date:  2015-07-11       Impact factor: 3.763

Review 4.  Understanding diabetic teratogenesis: where are we now and where are we going?

Authors:  Sheller Zabihi; Mary R Loeken
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2010-10

Review 5.  Pharmacological Management of Gestational Diabetes Mellitus.

Authors:  Riki Bergel; Eran Hadar; Yoel Toledano; Moshe Hod
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

Review 6.  Managing type 1 diabetes mellitus in pregnancy--from planning to breastfeeding.

Authors:  Lene Ringholm; Elisabeth R Mathiesen; Louise Kelstrup; Peter Damm
Journal:  Nat Rev Endocrinol       Date:  2012-09-11       Impact factor: 43.330

Review 7.  Diabetes mellitus in pregnancy. What are the best treatment options?

Authors:  E A Reece; C J Homko
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.228

8.  Octreotide therapy and restricted fetal growth: pregnancy in familial hyperinsulinemic hypoglycemia.

Authors:  Marianne Geilswijk; Lise Lotte Andersen; Morten Frost; Klaus Brusgaard; Henning Beck-Nielsen; Anja Lisbeth Frederiksen; Dorte Møller Jensen
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2017-02-15

9.  Fertility and pregnancy-associated ß-cell proliferation in mice deficient in proglucagon-derived peptides.

Authors:  Chisato Sugiyama; Michiyo Yamamoto; Tomomi Kotani; Fumitaka Kikkawa; Yoshiharu Murata; Yoshitaka Hayashi
Journal:  PLoS One       Date:  2012-08-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.